文献速递眼底病与葡萄膜炎白内障与屈光手术

无滴白内障手术后复方曲安奈德-莫西沙星致毒性后节综合征

TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN.
PubMed 文献 · Retina · 2020-01-01

回顾性病例复习报告7例无滴白内障手术后出现视力下降的患者,术后即刻最佳矫正视力平均20/220,出现闪光感、飞蚊症、畏光等症状,5例OCT显示椭圆体带丢失,电生理检查显示全视野ERG振幅等显著降低。结论认为这是首例由前房内复方曲安奈德-莫西沙星引起的毒性后节综合征病例系列,FDA将毒性归因于复方药物中黏合剂泊洛沙姆407水平异常升高。

要点

  • 无滴白内障手术使用复方曲安奈德-莫西沙星可致毒性后节综合征。
  • 术后即刻视力显著下降,平均BCVA 20/220,伴闪光感、飞蚊症等。
  • OCT可见椭圆体带丢失,电生理显示ERG振幅等显著降低。

核心结论

  • 这是首例无滴白内障手术后前房内复方曲安奈德-莫西沙星所致毒性后节综合征的病例系列。
  • FDA将毒性归因于复方药物中黏合剂泊洛沙姆407水平异常升高。
  • 临床医生应警惕此现象,使用复方药物时需谨慎。

研究设计与样本

  • 回顾性病例复习,纳入7例无滴白内障手术后视力下降的患者。

主要发现

  • 所有患者术后即刻术眼BCVA显著下降,范围20/40至4英尺数指,平均BCVA 20/220。
  • 症状包括闪光感、飞蚊症、畏光、眩光、光晕、视觉变形和辨色困难。
  • 3例散瞳眼底检查发现黄斑区视网膜色素上皮改变。
  • 7眼中5眼OCT显示椭圆体带丢失。
  • 7眼中5眼电生理检查显示全视野ERG振幅、振荡电位、多焦ERG和VEP大幅降低,伴负波型ERG。

临床怎么用

  • 临床医生应了解无滴白内障手术使用复方曲安奈德-莫西沙星可能导致毒性后节综合征。
  • 使用复方药物时应保持谨慎。

局限性

  • 原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report toxic posterior segment syndrome after dropless cataract surgery using locally compounded triamcinolone-moxifloxacin. METHODS: A retrospective case review of 7 patients presenting with a decrease in visual acuity after dropless cataract surgery. RESULTS: All patients experienced significant reductions in best-corrected visual acuity of the postoperative eye ranging from 20/40 to count finger at 4 feet (average best-corrected visual acuity 20/220) immediately after surgery. The presenting symptoms included flashes, floaters, photophobia, glare, halos, visual distortions, and problems assessing colors. In three cases, foveal retinal pigment epithelium changes were noted on dilated fundus exam (DFE). Ellipsoid zone loss was noted on ocular coherence tomography in five of the seven affected eyes. Electrophysiology testing in five of the seven affected eyes demonstrated large decreases in full-field electroretinogram amplitude, oscillatory potentials, multifocal electroretinogram, and visual evoked potential, along with a negative electroretinogram. One patient was treated with a dexamethasone implant, but no improvement in visual acuity was noted. CONCLUSION: This is the first case series of toxic posterior segment syndrome occurring secondary to intracameral compounded triamcinolone-moxifloxacin in dropless cataract surgery. The FDA has attributed the toxicity to abnormally high levels of the binding agent poloxamer 407 in the compounded medication. Clinicians should be aware of this phenomenon and exhibit caution when using compounded medications.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Patel SB, Reddy NK, He YG, et al. TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN. Retina. 2020. PMID: 30689622. doi:10.1097/IAE.0000000000002450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。